- Training
- 3 Hours
Global
- Training
- 2 Hours
Global
- Training
- 3 Hours
Global
- Training
- 8 Hours
Global
€3458EUR$3,500USD£2,878GBP
- Training
- 8 Hours
Global
€3458EUR$3,500USD£2,878GBP
- Training
- 4 Hours
Global
€3458EUR$3,500USD£2,878GBP
- Training
- 4 Hours
Global
€3458EUR$3,500USD£2,878GBP
- Training
- 6 Hours
Global
€1235EUR$1,250USD£1,028GBP
- Training
- 120 Minutes
Global
- Training
- 60 Minutes
Global
- Training
- 60 Minutes
Global
€6403EUR$6,480USD£5,329GBP
- Report
- August 2023
- 98 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- October 2024
- 87 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- August 2024
- 78 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- February 2024
- 102 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- February 2024
- 96 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- August 2023
- 99 Pages
Global
From €3500EUR$3,795USD£3,015GBP
- Report
- July 2023
- 102 Pages
Global
From €3500EUR$3,795USD£3,015GBP
The Drug Abuse Screening market is a sector of the healthcare industry that focuses on the detection and prevention of drug abuse. It involves the use of tests and screenings to identify individuals who are at risk of abusing drugs, as well as those who are already using them. These tests can be used to detect the presence of drugs in the body, as well as to measure the amount of drugs present. The results of these tests can then be used to inform treatment plans and interventions.
The Drug Abuse Screening market is made up of a variety of companies, including those that develop and manufacture drug testing kits, those that provide drug testing services, and those that provide software and other technology solutions for drug testing. Some of the major players in this market include Alere, Quest Diagnostics, LabCorp, and Psychemedics. Show Less Read more